
Sign up to save your podcasts
Or


Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719
By Michael Putman4.9
114114 ratings
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719

504 Listeners

298 Listeners

128 Listeners

3,374 Listeners

1,150 Listeners

120 Listeners

194 Listeners

518 Listeners

68 Listeners

5 Listeners

375 Listeners

183 Listeners

188 Listeners

19 Listeners

6 Listeners